Allison Dorval, CFO: Verve Therapeutics VERV Sell · Filed 25/04/03

Trade details

Type: Insider sale
Amount: $13,902.5
Shares · price: 3,350 sh · $4.15 a share
Held after: 13,280 sh
Stock: Verve Therapeutics VERV
Person: Allison DorvalCFO
Trade date: 25/04/02
Filed: 25/04/03
Days to filing: 1 days

Sold 20.1% of holdings

Share of holding sold: 20.1%

Verve Therapeutics trades, last 26 weeks

What else happened in Verve Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/03~25/05/02

Allison Dorval's recent trades

Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$83.6K
11,610 sh
$83.6K
Filed 06/15
Traded 06/12
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$84.3K
11,610 sh
$84.3K
Filed 06/12
Traded 06/12
Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$39.5K
11,610 sh
$39.5K
Filed 25/06/17
Traded 25/06/13
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$39.4K
11,610 sh
$39.4K
Filed 25/06/13
Traded 25/06/13
Allison DorvalCFO
SellVerve Therapeutics
Sell
Verve Therapeutics
VERV
$3,130
555 sh
$3,130
Filed 24/12/03
Traded 24/12/02